-
-
-
-
-
-
-
MATEON LAUNCHES ITS AI TELEMEDICINE PLATFORM FOR POST MARKETING SURVEY TO SUPPORT ITS DRUG PRODUCT FOR INDIA, PULMOHEAL™
-
-
-
-
-
-
-
MATEON THERAPEUTICS AND WINDLAS BIOTECH ENTER INTO DEFINITIVE AGREEMENT TO COMMERCIALZE ARTIVEDA™ AGAINST COVID-19
-
-
-
-
-
-
-
MATEON ANNOUNCES FIRST PATIENT ENROLLED IN ARTI-19: A MULTICENTER INTERVENTIONAL STUDY OF ARTISHIELD™ AGAINST COVID-19
-
-
-
-
-
-
-
MATEON THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS
-
-
-
-
-
-
-
Mateon Therapeutics to fund observational studies of Artemisinin in developing countries.
-
-
-
-
-
-
-
Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients
-
-
-
-
-
-
-
FDA Grants Pediatric Disease Designation for Mateon’s CA4P
-
924,013 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All